These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23912932)

  • 1. Current evidence on the relationship between SNP309 polymorphism in the MDM2 gene and colorectal cancer risk.
    Fu Q; Zhang G; Chen H; Zheng Y; Cheng J
    Tumour Biol; 2013 Dec; 34(6):3721-9. PubMed ID: 23912932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An updated meta-analysis on the association of MDM2 SNP309 polymorphism with colorectal cancer risk.
    Qin X; Peng Q; Tang W; Lao X; Chen Z; Lai H; Deng Y; Mo C; Sui J; Wu J; Zhai L; Yang S; Li S; Zhao J
    PLoS One; 2013; 8(9):e76031. PubMed ID: 24098760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDM2 SNP309 polymorphism is associated with colorectal cancer risk.
    Wang W; Du M; Gu D; Zhu L; Chu H; Tong N; Zhang Z; Xu Z; Wang M
    Sci Rep; 2014 May; 4():4851. PubMed ID: 24797837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDM2 SNP309 polymorphism and colorectal cancer risk: a meta-analysis.
    Cao X; Zhang T; Zhao Z; Zhao T
    DNA Cell Biol; 2012 Mar; 31(3):355-9. PubMed ID: 21770737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of Murine Double Minute 2 Genotypes to Colorectal Cancer Risk in Taiwan.
    Yueh TC; Hung YW; Shih TC; Wu CN; Wang SC; Lai YL; Hsu SW; Wu MH; Fu CK; Wang YC; Ke TW; Chang WS; Tsai CW; Bau DT
    Cancer Genomics Proteomics; 2018; 15(5):405-411. PubMed ID: 30194081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do CDKN2 p16 540 C>G, CDKN2 p16 580 C>T, and MDM2 SNP309 T>G gene variants act on colorectal cancer development or progression?
    Tuna G; Küçükhüseyin O; Arıkan S; Kaytan Sağlam E; Güler E; Cacına C; Oztop O; Turan S; Korkmaz G; Yaylım I
    DNA Cell Biol; 2013 Jul; 32(7):400-8. PubMed ID: 23777425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cigarette smoking, MDM2 SNP309, gene-environment interactions, and lung cancer risk: a meta-analysis.
    Bai J; Dai J; Yu H; Shen H; Chen F
    J Toxicol Environ Health A; 2009; 72(11-12):677-82. PubMed ID: 19492228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDM2 309T>G polymorphism and risk of squamous cell carcinomas of head and neck: a meta-analysis.
    Liu J; Zheng Y; Lei D; Liu D; Xu F; Jin T; Cao X; Zhao X; Yu X; Pan X
    Asian Pac J Cancer Prev; 2011; 12(8):1899-903. PubMed ID: 22292622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.
    Ma Y; Bian J; Cao H
    PLoS One; 2013; 8(2):e56918. PubMed ID: 23451111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDM2 SNP309 polymorphism and breast cancer risk: a meta-analysis.
    Zhao E; Cui D; Yuan L; Lu W
    Mol Biol Rep; 2012 Apr; 39(4):3471-7. PubMed ID: 21725850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis.
    Wan Y; Wu W; Yin Z; Guan P; Zhou B
    BMC Cancer; 2011 May; 11():208. PubMed ID: 21619694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of p53 R72P polymorphism in the association of MDM2-SNP309 with breast cancer.
    Leu JD; Wang CY; Tsai HY; Lin IF; Chen RC; Lee YJ
    Oncol Rep; 2011 Jun; 25(6):1755-63. PubMed ID: 21479369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM2 309 T/G polymorphism is associated with colorectal cancer risk especially in Asians: a meta-analysis.
    Fang F; Yu XJ; Yu L; Yao L
    Med Oncol; 2011 Dec; 28(4):981-5. PubMed ID: 20503107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis.
    Ding H; Dai Y; Ning Z; Fan N; Wang Z; Li P; Zhang L; Tao Y; Wang H
    Medicine (Baltimore); 2016 Mar; 95(12):e2941. PubMed ID: 27015167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis.
    Peng Q; Mo C; Qin A; Lao X; Chen Z; Sui J; Wu J; Zhai L; Yang S; Qin X; Li S
    J Exp Clin Cancer Res; 2013 Nov; 32(1):85. PubMed ID: 24423195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53 and MDM2 gene polymorphisms, gene-gene interaction, and hepatocellular carcinoma risk: evidence from an updated meta-analysis.
    Peng Q; Lao X; Chen Z; Lai H; Deng Y; Wang J; Mo C; Sui J; Wu J; Zhai L; Yang S; Qin X; Li S
    PLoS One; 2013; 8(12):e82773. PubMed ID: 24376578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between MDM2 SNP309 and endometrial cancer risk: A PRISMA-compliant meta-analysis.
    Zou X; Zhang Y; Zhang L; Li J; Zhu C; Cheng Q; Zhou J; Chen Y
    Medicine (Baltimore); 2018 Dec; 97(49):e13273. PubMed ID: 30544386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the Mdm2(SNP309-G) allele on a murine model of colorectal cancer.
    Zhang X; Pageon L; Post SM
    Oncogene; 2015 Aug; 34(33):4412-20. PubMed ID: 25435368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP53 Arg 72Pro and MDM2 SNP309 polymorphisms and colorectal cancer risk: a west Algerian population study.
    Abderrahmane R; Louhibi L; Moghtit FZ; Boubekeur A; Benseddik K; Boudjema A; Benrrahal F; Aberkane M; Fodil M; Saidi-Mehtar N
    Pathol Oncol Res; 2015 Jul; 21(3):629-35. PubMed ID: 25537146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDM2 SNP309 G allele increases risk but the T allele is associated with earlier onset age of sporadic breast cancers in the Chinese population.
    Lum SS; Chua HW; Li H; Li WF; Rao N; Wei J; Shao Z; Sabapathy K
    Carcinogenesis; 2008 Apr; 29(4):754-61. PubMed ID: 18281248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.